MattyTrader
9 meses hace
💸 $ARGQ
🎀 Pink Current Information
💰 0.02
🏛️ AS: 950M • R: 166.8M • UR: 23.55M • DTC: 12.59M
Facilities Description Changed:
❌ The Company and its subsidiaries operate from a 1,000 square foot office located at 27 Sheet Street,...
✅ The Company and its subsidiaries operate from an office located at Tyttenhanger House, Coursers Rd, ...
Address Changed:
❌ 27 Sheet Street
Windsor Berkshire SL4 1BN
United Kingdom
✅ Tyttenhanger House (Address1)
St Albans (City) AL4 0PG (Zip)
United Kingdom
✅ State Added: ENG
✅ Address2 Added: Coursers Rd
✅ Address3 Added: Colney Heath
✅ Twitter Added: https://www.twitter.com/argentum47inc
❌ Officers Removed:
• Stephen Jones (Managing Director, IT Operations)
• Daniel Triana (CMO)
• James Backhouse (CSO)
• Anthony Ryan (CTO)
• Gary Welbum (Director, Business Control)
OTCM Profile | Twitter | TradingView
2024-03-26 10:02:07 EDT | @ASE
Pokerpro05
1 año hace
https://www.accesswire.com/viewarticle.aspx?id=794446&lang=en
Capitalize on the Growing Market
Thursday, 19 October 2023 08:30
ACCESSWIRE | Article Logo
Argentum 47, Inc.
Share this Article
Share on Twitter
Share on Facebook
Share on Linkedin
Topic:
Company Update
WINDSOR, BERKSHIRE, UK / ACCESSWIRE / October 19, 2023 / Argentum 47, Inc. ("Argentum" or the "Company")(www.argq.io) (OTC PINK:ARGQ), a leading provider of AI-powered digital marketing solutions including branding, advertising, and lead generation, announced today that it has entered into talks with a European medical cannabis company that is fully integrated with strategic assets along the entire value chain including cultivation, processing, and distribution of dry flower and oil derivatives.
With the global medical cannabis market valued at USD $11.0 billion in 2021 and projected to reach USD $54.34 billion by 2029, (source: Data Bridge Market Research, July 2022), Argentum is striving to capitalize on the European cannabis industry, which is expected to grow significantly in the coming years as more countries legalize medicinal marijuana and its related products.
"This strategic expansion closely aligns with our mission of building shareholder value and fostering robust and sustainable growth. The surging European medical cannabis market is projected to reach unprecedented heights in the coming years, as an increasing number of countries progressively pass legislation and establish regulatory frameworks to meet the expected rising demand," said Argentum's CEO, Robert Stephenson. "The emergence of a legal framework for the industry has created opportunities for manufacturers, retailers, and consumers alike. In an increasingly competitive market, companies will need to innovate to stand out, and we believe that Argentum can deliver by strategically positioning itself to capitalize on this green field opportunity through the acquisition of a cutting-edge medical cannabis cultivation and processing facility that is planned to be operational in the first half of 2024."
About The Project
Argentum's comprehensive medical cannabis project, located near Lisbon, Portugal, will span 4.3 hectares, with an option for an additional 11.6 hectares. The facility's development is slated to roll out in three phases. Phase one, projected for completion by Q4 2023, includes a 3,500 m^2 production facility built to meet good manufacturing practices, or GMP, standards and a 1,880 m^2 state-of-the-art greenhouse. Phase two and three will aim to maximize output with expansion of greenhouse space and EU-GMP extraction capabilities for medical oil production that will result in an 18,000 kg GMP-compliant facility.
To enhance the Company's EU market presence, ensure broad product accessibility and bolster distribution across the European Union, Argentum plans to refine marketing strategies for initial territories in Malta, the Czech Republic, Poland, and Germany, and extend out to other markets as they emerge.
LOLOLOLOLOLOLOLOLOL!!!!!!!! Enzo and Petey sell outs! Now this clown show!!!! LOL!!!!!
Geesh, just another freaking stinky pinky!
Pokerpro05
molee
1 año hace
Argentum 47, Inc. Provides Business Update on Growth Initiatives
WINDSOR, BERKSHIRE, UK / ACCESSWIRE / October 10, 2023 / Argentum 47, Inc. (www.argq.io) (OTC PINK:ARGQ), a global diversified holding company specializing in AI-driven technology, web-based services, and marketing solutions, is delighted to share a business update from its Chief Executive Officer, Robert Stephenson.
Argentum 47, Inc. remains committed to its expansion, enhancing its proprietary technological capabilities, and establishing its position at the cutting edge of innovation. Since the last update, Argentum 47 has made good strides towards accelerating its growth trajectory through strategic plans and partnerships.
In Q4 2022, the Company aligned itself with a renowned firm based in New York City that is known for providing strategic financial advice, creating a path to fair valuations, and facilitating effective business conversations. In Q1 2023, the Company engaged an innovative firm from Toronto, Canada offering digital front management and shareholder engagement for small and medium-sized public companies. These partnerships represent important additions to Argentum 47, Inc.'s growth strategy, as the Company strives to strengthen its market positioning.
During Q1 2023, our Management Team spoke with a diverse group of investors and advisors, which has led to an increased understanding of what's needed to advance the Company's strategic plans and laying the groundwork for potential partnerships and funding opportunities. The Company is exploring several funding options to accelerate growth.
The Company has also successfully eliminated all legacy debt and is progressing toward meeting the requirements to uplist to the OTC Markets OTCQB trading tier in Q4 2023. This will be a significant milestone for Argentum 47 as an uplist generally provides more transparency and liquidity for its investors. Our vision is to invest future funding to bolster our technological framework in order to enable the Company to conceive, develop, and manage its proprietary technology in-house, as well as to acquire cutting-edge technology in an effort to stay ahead of the AI curve.
Argentum 47, Inc. remains committed to its mission of creating and delivering unmatched value to its shareholders as the company moves forward. The Company's journey would not be possible without the unwavering support and trust of our shareholders, for which it is extremely grateful.